This unique event is sure to be a great one. Please take the following three steps in order to fully participate in this event.
Take the time now to register and join us on November 15th at 3 PM Eastern as we host a Q&A session with Nobel Prize winner and immunotherapy pioneer, Dr. Jim Allison, and his genius wife, Dr. Padmanee Sharma, a renowned genitourinary cancer doctor. Both Dr. Allison and Dr. Sharma currently practice at MD Anderson Cancer Center in Houston, Texas. A large number of immunotherapy treatments are currently in development for AML. This is the perfect opportunity to ask the experts about what this could mean for you and your treatment.
After signing up for the Q&A session, now it's time to watch the documentary. You can access the documentary for free up until November 14th, 2021.
Get Access to the Jim Allison Documentary
After signing up, the free link to the documentary will be sent to you via email right away.
All questions for this event must be submitted by November 12th. No questions submitted during the meeting will be answered.
Please submit your questions here:
Questions for the Jim Allison: Breakthrough Q&A Event
We are so excited for you to join us. Please share with any family or friends that might be interested!
HealthTree Foundation Founder and President, Blood Cancer Survivor
Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center
professor of Genitourinary Medical Oncology and Immunology in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
(800) 930-5159
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.